676
Views
1
CrossRef citations to date
0
Altmetric
Clinical Research

Factors associated with prolonged intensive care stay among self-poisoned patients

, , , , , , , , , & ORCID Icon show all
Pages 997-1005 | Received 12 Feb 2022, Accepted 06 Apr 2022, Published online: 22 Apr 2022

Figures & data

Figure 1. Flow chart.

Figure 1. Flow chart.

Table 1. Comparisons between self-poisoned patients with ICU stay of more and less than seven days.

Figure 2. Drugs involved in self-poisoned patients with prolonged ICU stay of ≥7 days (n = 23) and shorter ICU stay of <7 days (n = 23). ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; GHB, gamma-hydroxybutyrate; SSRI, selective serotonin reuptake inhibitors; NSAID, non-steroidal anti-inflammatory drug. Street drugs included the followings: cocaine, amphetamines, GHB, heroin, ketamine, synthetic cathinones, poppers, and cannabis.

Figure 2. Drugs involved in self-poisoned patients with prolonged ICU stay of ≥7 days (n = 23) and shorter ICU stay of <7 days (n = 23). ACEI, angiotensin-converting-enzyme inhibitor; ARB, angiotensin II receptor blocker; GHB, gamma-hydroxybutyrate; SSRI, selective serotonin reuptake inhibitors; NSAID, non-steroidal anti-inflammatory drug. Street drugs included the followings: cocaine, amphetamines, GHB, heroin, ketamine, synthetic cathinones, poppers, and cannabis.

Table 2. Characteristics of 239 self-poisoned patients with prolonged ICU stay of more than seven days.

Table 3. Risk factors for prolonged ICU stay in self-poisoned patients based on a multivariate analysis.

Supplemental material

Supplemental Material

Download PDF (579.3 KB)

Supplemental Material

Download Zip (551.4 KB)

Data availability statement

Prof. Mégarbane have full access to all data and takes responsibility for the data integrity and its analysis accuracy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.